Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Dec 31, 2018
Company News

Heron's non-opioid HTX-011 gets Priority Review

BioCentury | Jun 21, 2018
Clinical News

Heron flying on Phase IIb pain data ahead of NDA

BioCentury | Mar 30, 2018
Financial News

Pain company Heron raises $156M follow-on

BioCentury | Mar 29, 2018
Financial News

Pain company Heron raises $156M

BioCentury | Feb 16, 2017
Clinical News

HTX-011: Ph II Study 203 data

BioCentury | Jan 19, 2017
Financial News

Heron raises $150M in follow-on

Items per page:
1 - 10 of 18